Modern Management of Anthracycline‐Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin

BACKGROUND. Anthracyclines (AC) are still undeniable drugs in lymphoma treatment, despite occasionally causing cardiotoxicity. Liposomal AC may reduce cardiotoxicity while retaining clinical efficacy; also, biomarker monitoring during chemotherapy allows early detection of cardiac damage, enabling s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Olivieri, Jacopo, Perna, Gian Piero, Bocci, Caterina, Montevecchi, Claudia, Olivieri, Attilio, Leoni, Pietro, Gini, Guido
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2017
Konular:
Hematologic Malignancies
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5388379/
https://ncbi.nlm.nih.gov/pubmed/28275118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0289
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller